Greenyard Pharmaceutical’s Mental Health Business Unit specialises in the treatment of patients with Schizophrenia and Opioid Addiction.
Mental health
Addiction withdrawal
Our lofexidine tablets (Britlofex) offer a different way of treating opioid addiction by focussing on withdrawal and detoxification instead of long-term harm reduction through prescribed maintenance therapy.
The withdrawal process typically takes less than 14 days, and Lofexidine can help with a reduction in the side-effects normally associated with detox from both heroin and opiate-based prescription pharmaceuticals.
Schizophrenia
Greenyard Pharmaceutical offers a fully integrated web-based blood monitoring service, utilised by specialist mental health hospital pharmacies to enable dispensing decisions for our clozapine (Denzapine) therapy for treatment of resistant schizophrenia. In the US, all forms of Clozapine are similarly restricted on patient safety grounds.
Our Near Patient Testing (NPT) machines are installed in an increasing number of local medical facilities, helping to maintain patient well-being by allowing them access to their medication under the guidance of their trusted healthcare professionals in the community.
Greenyard Pharmaceutical manages the process through our highly-trained monitoring team, dedicated to maximising patient safety while taking clozapine treatment.
withdrawal and detoxification instead of long-term harm reduction through prescribed maintenance therapy.
The withdrawal process typically takes less than 14 days, and Lofexidine can help with a reduction in the side-effects normally associated with detox from both heroin and opiate-based prescription pharmaceuticals.